Determination of the pharmacogenetic and pharmacoproteomic response of antiosteoporotic therapies in cardiovascular disease in patients with type 2 diabetes mellitus
FEIOMM17-001/PI
Year of the call
2017
Execution date
06/11/2017 - 30/11/2019
FEIOMM17-001/PI
2017
06/11/2017 - 30/11/2019